Superior Bioavailability of a Novel Curcumin Formulation in Healthy Humans Under Fasting Conditions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Superior Bioavailability of a Novel Curcumin Formulation in Healthy Humans Under Fasting Conditions ; volume:39 ; number:5 ; day:16 ; month:3 ; year:2022 ; pages:2128-2138 ; date:5.2022
Advances in therapy ; 39, Heft 5 (16.3.2022), 2128-2138, 5.2022
- Urheber
-
Kothaplly, Sudhakar
Alukapally, Shankar
Nagula, Nagaraju
Maddela, Rambabu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-022-02081-w
- URN
-
urn:nbn:de:101:1-2022071011104486982743
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kothaplly, Sudhakar
- Alukapally, Shankar
- Nagula, Nagaraju
- Maddela, Rambabu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Superior Bioavailability of a Novel Lutein and Zeaxanthin Formulation in Healthy Human Subjects
Curcumin : bioavailability and bioactivity in relation to aging
Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats
Relative bioavailability of curcumin as affected by formulation strategies : from in vitro digestion and cell culture experiments to human clinical trials
ι-Carrageenan nanocomposites for enhanced stability and oral bioavailability of curcumin
Bioavailability of a Capsaicin Lipid Multi-particulate Formulation in Rats
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
Correction to: Bioavailability of a Capsaicin Lipid Multi‑particulate Formulation in Rats
Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects
Formulation and evaluation of curcumin microsponges for oral and topical drug delivery
Formulation and characterization of nanofibrous scaffolds incorporating extracellular vesicles loaded with curcumin
Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis
Superior Bioavailability of a Novel Lutein and Zeaxanthin Formulation in Healthy Human Subjects
Curcumin : bioavailability and bioactivity in relation to aging
Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats
Relative bioavailability of curcumin as affected by formulation strategies : from in vitro digestion and cell culture experiments to human clinical trials
ι-Carrageenan nanocomposites for enhanced stability and oral bioavailability of curcumin
Bioavailability of a Capsaicin Lipid Multi-particulate Formulation in Rats
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
Correction to: Bioavailability of a Capsaicin Lipid Multi‑particulate Formulation in Rats
Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects
Formulation and evaluation of curcumin microsponges for oral and topical drug delivery
Formulation and characterization of nanofibrous scaffolds incorporating extracellular vesicles loaded with curcumin
Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis
Superior Bioavailability of a Novel Lutein and Zeaxanthin Formulation in Healthy Human Subjects
Curcumin : bioavailability and bioactivity in relation to aging
Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats
Relative bioavailability of curcumin as affected by formulation strategies : from in vitro digestion and cell culture experiments to human clinical trials
ι-Carrageenan nanocomposites for enhanced stability and oral bioavailability of curcumin
Bioavailability of a Capsaicin Lipid Multi-particulate Formulation in Rats
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
Correction to: Bioavailability of a Capsaicin Lipid Multi‑particulate Formulation in Rats
Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects
Formulation and evaluation of curcumin microsponges for oral and topical drug delivery
Formulation and characterization of nanofibrous scaffolds incorporating extracellular vesicles loaded with curcumin